Five issues in healthcare were spotlighted as key developments to watch; FDA to ban all e-cig vape flavors except for menthol and tobacco; Google AI system shown to improve detection of breast cancer through mammograms.
In an article published by The Hill, 5 key issues relating to healthcare warrant extensive monitoring: drug pricing, surprise billing, the Affordable Care Act (ACA), Medicare for All, and vaping. All topics have become talking points throughout 2019, with drug prices and surprise medical bills serving as the focus of bipartisan talk but no major reforms have been initiated yet. The ACA is also a trending topic with the end of the past year seeing the law deemed unconstitutional by a federal appeals court. The FDA plans to ban all e-cigarette vaping flavors except for tobacco and menthol, according to The Wall Street Journal. The ban seeks to impede the teen vaping epidemic, with fruity vaping flavors such as bubble gum shown to attract teenagers and consequently lead to nicotine addiction. The ban will also exclude open-tank vaping devices, which allow users to mix their own nicotine liquids. The official announcement is expected to come tomorrow.A Google AI system was shown in a study to be as good as expert radiologists at detecting off mammograms which women had breast cancer and showed potential at reducing errors, according to Reuters. The study, published in the journal Nature, adds to research showing the promise of AI systems in reducing errors relating to diagnosing breast cancer, with radiologists shown to miss about 20% of breast cancers in mammograms.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
FDA Approves Danziten for Chronic Myeloid Leukemia Without Mealtime Restrictions
November 14th 2024The FDA has granted approval to Azurity Pharmaceuticals' nilotinib tablets (Danziten), a novel version of the tyrosine kinase inhibitor for chronic myeloid leukemia that can be taken without mealtime restrictions.
Read More
Bridging Cancer Care Gaps and Overcoming Medical Mistrust
November 13th 2024In this clip from our interview with Oscar B. Lahoud, MD, cochair of our Institute for Value-Based Medicine® evening hosted with NYU Langone Health, he addressed medical mistrust in underrepresented communities.
Read More